an advancedclinical vaccine trial at the beginning of August. Dr. Nicola (NICK-oh-la) Klein, director of the Kaiser Permanente Vaccine Study Center spoke with KRCB’s Adia White. Adia starts by asking what happens during a so-called “phase three” trial, and when a safe and effective vaccine might be ready for general use.

For more local coronavirus updates, visit norcalpublicmedia.org

(Photo: Dr. Nicola Klein – Kaiser Permanente)

Podcast: Play in new window | Download

Subscribe: Android | Google Podcasts | RSS

Northern California
Public Media Newsletter

Get the latest updates on programs and events.